TrendingWallStreet.com Initiates Market Research on OSGIQ, DRI, ALIM, and GRPN


Follow this company

Companies Mentioned

PK:OSGIQ / NASDAQ:DRI / NASDAQ:ALIM / NASDAQ:GRPN
12/20/2013 [ACCESSWIRE]

Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.

Overseas Shipholding Group Inc. (OTC: OSGIQ) shares closed up 35.96 percent on a little over 2 million shares traded. The stock was one of the biggest gainers in the OTC market. The stock hit a new 52-week high of $6.32 during intra-day trading. On November 14, 2012, Overseas Shipholding Group, Inc. and certain of its subsidiaries filed voluntary petitions for reorganization under Chapter 11 of Title 11 of the U.S. Code in the Bankruptcy Court for the District of Delaware.

Get more information on Overseas Shipholding Group Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/OSQIQ

Darden Restaurants, Inc. (NYSE: DRI) shares closed down 3.59 percent on nearly 15 million shares traded on Thursday. The stock was one of the most active stocks on the NYSE. The company said Thursday that it is looking to either spin off or sell Red Lobster as part of its plan to boost value for its shareholders. Those plans also include suspending the opening of new Olive Garden locations and limiting the launch of new LongHorn Steakhouse restaurants.

Get more information on Darden Restaurants, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/DRI

Alimera Sciences, Inc. (NASDAQ: ALIM) shares closed up 62.75 percent on Thursday with about 4.3 million shares traded. The stock had one of the largest volume increases on the NASDAQ. Both shares of Alimera Sciences and pSivida continued to climb Thursday, a day after the companies announced that no further clinical trials would be required before federal regulators make a call on whether to approve the eye disease treatment Iluvien.

Get more information on Alimera Sciences, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/ALIM

Groupon, Inc. (NASDAQ: GRPN) shares closed up 3.37 percent on Thursday with about 26.8 million shares traded. The stock was one of the most active stocks on the NASDAQ. The stock has reached its highest level in 2 months. Northland Capital Markets analyst Darren Aftahi initiated coverage on Groupon with an outperform, or buy rating, and $13-a-share price target.

Get more information on Groupon, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/GRPN

 

Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.

COMMENTS

Leave a comment...
 * 

Your Name
 *